Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck KGaA Is Latest Partner For C4 Therapeutics’ Protein Degradation

Mar 05 2024

• By Andrew McConaghie

merck kgaa — • Source: Merck KGaA

Related Content

Merck’s Focus On ADCs Expands To Include Protein Degraders With C4

Dec 12 2023

Related Companies

C4 Therapeutics, Inc.

Merck KGaA

Merck & Co., Inc.

GSK plc

AstraZeneca PLC

Bristol Myers Squibb Company

Pfizer Inc.

Arvinas, Inc.

Additional Topics

Deals Companies Research & Development StartUps and SMEs Clinical Trials Commercial Cancer BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window